IP Library Granted Patent US 7,488,601
Granted Patent B2
US 7,488,601 · App. 10/688,561 · Granted Feb 10, 2009

System and method for determining an abused sensor during analyte measurement

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,488,601
App. No.
10/688,561
Granted
Feb 10, 2009
Kind
B2
Abstract

A method of measuring an analyte in a biological fluid comprises applying an excitation signal having a DC component and an AC component. The AC and DC responses are measured; a corrected DC response is determined using the AC response; and a concentration of the analyte is determined based upon the corrected DC response. Other methods and devices are disclosed.

Claims (39)

1. A method for detecting an abused sensor adapted for determining a concentration of a medically significant component of a biological fluid, comprising the steps of:

a) applying a signal having an AC component to the sensor;

b) measuring an AC response to the signal; and

c) using the AC response to determine if the sensor is abused, wherein steps (a), (b) and (c) are performed before application of the biological fluid to the sensor.

2. The method of claim 1 , wherein the AC response comprises an admittance.

3. The method of claim 1 , wherein the signal is an AC signal.

4. The method of claim 1 , wherein the AC response comprises phase angle information.

5. The method of claim 1 , wherein the AC component of the signal has a frequency not less than 1 Hz and not greater than 20 kHz.

6. The method of claim 1 , wherein the biological fluid is blood.

7. A method for detecting an abused sensor for determining a concentration of a medically significant component of a biological fluid placed upon the sensor, comprising the steps of:

a) placing the biological fluid sample upon the sensor;

b) applying a first signal to the biological fluid;

c) measuring a current response to the first signal;

d) repeating step (c) at least once;

e) calculating a normalized Cottrell Failsafe Ratio using the current response data;

f) applying a second signal having an AC component to the biological fluid;

g) measuring an AC response to the second signal; and

h) combining the normalized Cottrell Failsafe Ratio and the AC response to produce an indication of whether the sensor has been abused, wherein step (h) comprises calculating a FAILSAFE number as follows:

FAILSAFE=1000×arctan [ NCFR /( fs 0 +fs 1 (Φ 1 −Φ 2 ))]

where: 1000=scaling factor

NCFR normalized Cottrell Failsafe Ratio

fs 0 =constant

fs 1 =constant

Φ 1 =phase angle at a first frequency

Φ 2 =phase angle at a second frequency;

wherein a value of FAILSAFE below zero indicates an abused sensor and a value of FAILSAFE above zero indicates a non-abused sensor.

8. A method of determining a failure condition indicating an abused sensor in a blood glucose concentration test, comprising the steps of:

a) applying a first test signal having an AC component to a test sample;

b) measuring a first phase angle response to the first test signal;

c) applying a second test signal having an AC component to the test sample;

d) measuring a second phase angle response to the second test signal; and

e) determining a failure condition value based upon the first phase angle response the second phase angle response and a predetermined Cottrell Failsafe Ratio, wherein step (e) is performed based at least in part upon evaluating:

arctan [CFR/(fs 0 +fs 1 (Φ A −Φ B )]

where:

CFR=Cottrell Failsafe Ratio

fs 0 =a constant

fs 1 =a constant

Φ A =first phase angle response

Φ B =second phase angle response.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 23, 2015
From: ROCHE DIAGNOSTICS OPERATIONS, INC.
To: ROCHE DIABETES CARE, INC.
Reel/Frame 036008/0670 →
CHANGE OF NAME Recorded Dec 17, 2008
From: CORANGE INTERNATIONAL LIMITED
To: ROCHE OPERATIONS LTD.
Reel/Frame 021993/0943 →
ASSIGNOR HEREBY CONFIRMS THE ASSIGNMENT TO CORANGE INTERNATIONAL LIMITED OF AN UNDIVIDED ONE-HALF INTEREST IN EACH OF THE APPLICATIONS Recorded Jun 13, 2007
From: ROCHE DIAGNOSTICS OPERATIONS, INC.
To: CORANGE INTERNATIONAL LIMITED
Reel/Frame 019419/0381 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 16, 2004
From: ROCHE DIAGNOSTICS CORPORATION
To: ROCHE DIAGNOSTICS OPERATIONS, INC.
Reel/Frame 015201/0368 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 1, 2004
From: BURKE, DAVID W.; KUHN, LANCE S.; MAXWELL, JAMES J.
To: ROCHE DIAGNOSTICS OPERATIONS, INC.
Reel/Frame 014482/0402 →